The abstract is read at the publisher; the summary is JClub's.
Elevated histone 3 lysine 18 lactylation (H3K18la) in colorectal cancer-associated fibroblasts is linked to myofibroblastic CAF transition, increased collagen deposition, and enhanced organoid growth.
- Why it matters: CAF heterogeneity in cytokine signaling limits therapies, so metabolic and epigenetic mechanisms that coordinate CAF communication and tumor support are needed as actionable targets in CRC.
- What they did: Metabolomic and single-cell RNA-seq profiling compared CAFs versus normal fibroblasts, and fibroblast-specific conditional Ldha knockout in mice tested lactate-driven effects; TGF-β and NPM1 were examined for H3K18la control.
- The result: CAF histone lactylation is shown to require the RhoA/ROCK1/MLC2/MRTF-A axis and ECM remodeling to promote CRC progression and suppress CD8+ T cell infiltration/exhaustion, while stiripentol enhanced immunotherapy efficacy in CRC models.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.